Sanofi SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Sanofi SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4425
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi SA – Strategy, SWOT and Corporate Finance Report
Summary

Sanofi SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanofi SA (Sanofi or ‘the group’) is a France-based international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. In addition, it provides prescription products, consumer healthcare products, generics, and vaccines. It offers products related to Vaccines that include pediatric vaccines for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (Hib), influenza vaccines and adult and adolescent booster vaccines. The group operates across North America and Europe. Sanofi is headquartered in Paris, France.

Scope

- Detailed information on Sanofi SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments
- Intelligence on Sanofi SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanofi SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sanofi SA: Company Overview 9
Sanofi SA: Overview and Key Facts 9
Sanofi SA: Overview 9
Sanofi SA: Key Facts 9
Sanofi SA: Key Employees 11
Sanofi SA: Key Employee Biographies 13
Sanofi SA: Major Products and Services 14
Sanofi SA: Company History 15
Sanofi SA: Management Statement 27
Sanofi SA: Locations and Subsidiaries 29
Sanofi SA: Key Competitors 30
Sanofi SA: Company Analysis 31
Sanofi SA: Business Description 31
Sanofi SA: SWOT Analysis 33
Sanofi SA: SWOT Overview 33
Sanofi SA: Strengths 33
Sanofi SA: Weaknesses 34
Sanofi SA: Opportunities 34
Sanofi SA: Threats 34
Sanofi SA: Corporate Financial Deals Activity 37
Sanofi SA: Financial Deals Overview 37
Sanofi SA: Targets and Partners 39
Sanofi SA: Top Deals 2014 – 2018YTD* 42
Sanofi SA: Advisors 43
Sanofi SA: Top Legal Advisors 43
Sanofi SA: Top Financial Advisors 43
Sanofi SA: Mergers and Acquisitions 45
Sanofi SA: Corporate Venturing 46
Sanofi SA: Capital Raising 47
Sanofi SA: Partnership 48
Sanofi SA: Divestments 49
Sanofi SA: Recent Developments 50
Sanofi SA: News and Events Summary 50
Sanofi SA: Business Expansion 54
Sanofi SA: Contracts 55
Sanofi SA: Corporate Governance 56
Sanofi SA: Financial Deals 57
Sanofi SA: Regulatory and Legal Events 57
Sanofi SA: Strategy and Operations 58
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Sanofi SA: Key Facts
Table 2: Sanofi SA: Key Employees
Table 3: Sanofi SA: Locations and Subsidiaries
Table 4: Sanofi SA: Key Competitors
Table 5: Sanofi SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sanofi SA: M&A Activity by Geography (TTM*)
Table 7: Sanofi SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Sanofi SA: M&A Average Deal Size - Value (US$m)
Table 9: Sanofi SA: Targets and Partners
Table 10: Sanofi SA: Top Deals 2014 - 2018YTD*
Table 11: Sanofi SA: Legal Advisor Ranking by Value (US$m)
Table 12: Sanofi SA: Financial Advisor Ranking by Value (US$m)
Table 13: Sanofi SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Sanofi SA: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Sanofi SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Sanofi SA: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Sanofi SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Sanofi SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Sanofi SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Sanofi SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Sanofi SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Sanofi SA: Divestments by Geography (2014 - YTD*2018)
Table 23: Sanofi SA: News and Events Summary
Table 24: Sanofi SA: Business Expansion
Table 25: Sanofi SA: Contracts
Table 26: Sanofi SA: Corporate Governance
Table 27: Sanofi SA: Financial Deals
Table 28: Sanofi SA: Regulatory and Legal Events
Table 29: Sanofi SA: Strategy and Operations

List of Figures
Figure 1: Sanofi SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sanofi SA: M&A Activity by Geography (TTM*)
Figure 3: Sanofi SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Sanofi SA: M&A Average Deal Size - Value (US$m)
Figure 5: Sanofi SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sanofi SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Sanofi SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Sanofi SA: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Sanofi SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Sanofi SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Sanofi SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Sanofi SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Sanofi SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: Sanofi SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Sanofi SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cyclenium Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyclenium Pharma Inc (Cyclenium Pharma) is a pharmaceutical research and development company that offers small molecule therapeutics agent producer for drug discovery. The company employs its proprietary customized macrocycles for recognition of topologies technology for discovering and deve …
  • McCain Foods Ltd:戦略・SWOT・企業財務分析
    McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Comrod Communication ASA:企業の戦略・SWOT・財務情報
    Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report Summary Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tissue Regenix Ltd:企業の製品パイプライン分析
    Summary Tissue Regenix Ltd (Tissue Regenix), a subsidiary of Tissue Regenix Group PLC, is a medical technology company that offers replacement body parts from biological materials by using the dCELL technology platform. The company’s proprietary dCELL technology process is applied in markets such as …
  • Petroperu SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroperu SA (Petroperu) is an oil and gas company that offers transportation, refining, distribution and commercialization of fuels and petroleum products. The company offers vehicular, aviation, marine, industrial and domestic products. Its vehicular products include GLP, gasohol, gasoline …
  • Alltech Inc:企業の戦略的SWOT分析
    Alltech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • DxTerity Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • DIA Imaging Analysis Ltd-医療機器分野:企業M&A・提携分析
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a healthcare technology company that offers medical imaging analysis software solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. DiACardio’s LVivo SWM is a fully automated echo device or …
  • IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • Shuwen Biotech Co Ltd:企業の製品パイプライン分析2018
    Summary Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech dev …
  • Xellia Pharmaceuticals ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • R-Biopharm AG:医療機器:M&Aディール及び事業提携情報
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical di …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • BL&H Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Outset Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Outset Medical, Inc., (Outset Medical) is a medical technology company engaged in developing hemodialysis system for the treatment of kidney diseases. The company offers Tablo Hemodialysis machine that makes water clean, produces dialysate, takes blood pressure, and delivers medication for p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆